CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $258,000 | +171.6% | 49,008 | +3.2% | 0.00% | – |
| Q3 2016 | $95,000 | -3.1% | 47,476 | -0.2% | 0.00% | – |
| Q2 2016 | $98,000 | +40.0% | 47,583 | +46.4% | 0.00% | – |
| Q1 2016 | $70,000 | -30.7% | 32,501 | -7.1% | 0.00% | – |
| Q4 2015 | $101,000 | -32.2% | 34,979 | +4.6% | 0.00% | – |
| Q3 2015 | $149,000 | -15.8% | 33,443 | -2.6% | 0.00% | – |
| Q2 2015 | $177,000 | -17.7% | 34,325 | +13.7% | 0.00% | – |
| Q1 2015 | $215,000 | +14.4% | 30,191 | +12.1% | 0.00% | – |
| Q4 2014 | $188,000 | +79.0% | 26,925 | +57.2% | 0.00% | – |
| Q3 2014 | $105,000 | -37.1% | 17,129 | -6.8% | 0.00% | – |
| Q2 2014 | $167,000 | -87.6% | 18,370 | -88.9% | 0.00% | – |
| Q1 2014 | $1,342,000 | +30.2% | 164,931 | +3.2% | 0.00% | – |
| Q4 2013 | $1,031,000 | -38.7% | 159,860 | -4.4% | 0.00% | -100.0% |
| Q3 2013 | $1,681,000 | – | 167,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |